The multi-billion dollar endovascular device market

Endovascular treatment device market

The value of the endovascular treatment device market will reach over USD 5.77 billion by 2030;

Market Summary –

A newly published report titled “Global Endovascular Treatment Devices Market (Product (Percutaneous Endovascular Aneurysm Repair (EVAR), Fenestrated EVAR, Aortic Stents, Biodegradable Stents, Self-Expanding Nitinol Stents, Thoracic Aortic Aneurysm Grafts and Other Devices), Procedure (Balloon Angioplasty, Angioplasty with stent replacement, drug-eluting stents Carotid angioplasty and stenting, thrombosis, renal artery

Angioplasty and stenting, transfemoral carotid artery revascularization, endovascular brachytherapy, carotid stenting), application (pulmonary, vascular, cardiac surgery, neurology and radiology)) – according to trends, industry competition analysis, Covid-19 analysis, revenues (billions of US dollars) ) and forecast until 2030 by InsightAce Analytic Pvt. Ltd. provides detailed industry analysis and extensive market research examining its important factors.
The global endovascular market is estimated to reach over USD 5.77 billion by 2030, registering a CAGR of 8.52% during the forecast period.

Get a free sample copy of the report: https://www.insightaceanalytic.com/request-sample/1364

Advanced minimally invasive procedures such as endovascular surgery are used to treat conditions involving blood arteries such as aneurysms and bulging or “ballooning” of blood vessels. At the beginning of the procedure, an incision is made in the body to gain access to the blood vessels. A flexible plastic tube, stent, or catheter is then placed into the damaged blood artery to allow the patient’s bloodstream to administer or withdraw the drug. Endovascular therapeutic devices are used in chemotherapy, blood transfusions, intravenous antibiotic therapy and long-term intravenous nutrition.

The endovascular treatment devices market is expected to grow during the forecast period owing to factors such as aging population, increasing incidence of cardiovascular diseases, technologically advanced endovascular products, and increased R&D spending by market participants. The high cost of endovascular surgery, lack of understanding in developing countries, and shortage of qualified surgeons to perform the procedures hinder the market growth. Thanks to product innovation and increased healthcare spending, the number of endovascular devices has increased, driving research and development.

List of prominent players in the endovascular treatment device market:

Medtronic
Lombord’s doctor
Penumbra limited liability company
Terum company
Cardinal’s health
Endospan
Getting AB
Bosten Science Corporation
Inspire MD
Japan Lifeline Co., Ltd.

Market dynamics:
Drivers-
In the coming years, market growth will also be driven by the high incidence of abdominal aortic aneurysms, which are more common in men, and the potential increase in demand for minimally invasive techniques such as endovascular surgery. According to screening studies, the majority of abdominal aortic aneurysms (AAA), which mainly affect men, range from 4% to 8%. Due to the growing geriatric population worldwide, the incidence of AAA is high in the aging population and may become significant in the future. The market for endovascular treatment devices will continue to grow due to rapid technological progress and significant progress in minimally invasive surgery.

Challenges:
The major hindrances in the global endovascular therapy devices market are expected to include high costs associated with the use of new endovascular therapy devices, lack of awareness in economically underdeveloped countries, and stringent tax regulations in the US for medical products.

Regional trends:
The North American endovascular treatment device market is expected to record significant market share in revenue and will soon grow at a high CAGR. The market has expanded due to the increase in surgical procedures and the demand from medical professionals for these devices, which has prompted large companies to focus on developing cutting-edge medical devices in these countries. The endovascular therapy device market in the region will grow due to the obesity and diet epidemic, as well as the development of new products thanks to prominent manufacturers.

Additionally, the Asia-Pacific region accounted for significant share in the endovascular treatment device market. Increased medical advancements have contributed to the growth of endovascular treatment device market revenues in this area, which has led to the continuous growth of the industry. The growth can also be attributed to increased research and development efforts and medical advances made by significant players in countries in the region.

Inquiry before purchasing: https://www.insightaceanalytic.com/enquiry-before-buying/1364

Last changes:
In November 2021, Endospan published the results of safety and performance studies after 30 days and one year of use of off-the-shelf Nexus endovascular grafts intended for the treatment of thoracic aortic injuries involving the aortic arch.
In September 2021, Boston Scientific Corporation agreed to acquire Devoro Medical, developer of the WOLF thrombectomy platform, to expand its interventional techniques for the treatment of thromboembolism, including the EkoSonic endovascular system.
Segmentation of the endovascular treatment device market

By product-
• Percutaneous endovascular aneurysm repair (EVAR)
• Windowed EVAR
• Aortic stents Biodegradable stents
• Self-expanding nitinol stents
• Thoracic aortic aneurysm grafts
• Other devices

According to the procedure-
• Balloon angioplasty
• Angioplasty with stent replacement
• Drug-eluting stents Renal artery angioplasty and carotid artery stenting
• Thrombosis
• Angioplasty and renal artery stenting
• Transfemoral carotid artery revascularization
• Endovascular brachytherapy
• Carotid artery stenting

By App-
• Pulmonary
• Vascular
• Cardiac surgery
• Neurology
• Radiology
By region-
North America-
• United States
• Canada
• Mexico

Europe-
• Germany
• Great Britain
• France
• Italy
• Spain
• Rest of Europe

Asia-Pacific-
• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia-Pacific

Latin America-
• Brazil
• Argentina
• Rest of Latin America

Middle East and Africa-
• GCC countries
• South Africa
• Rest of the Middle East and Africa

For customization: https://www.insightaceanalytic.com/customisation/1364

Contact us:
InsightAce Analitics Pvt. Sp. z o. o
Tel.: +1 718 593 4405
E-mail: [email protected]
Site visit: www.insightaceanalytic.com
Follow us on LinkedIn @ bit.ly/2tBXsgS
Follow us on Facebook @ bit.ly/2H9jnDZ

About us:
InsightAce Analytic is a market research and consulting company that empowers clients to make strategic decisions.
Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to grow businesses.
We help clients gain competitive advantage by identifying untapped markets, discovering new and competitive technologies, segmenting potential markets and repositioning products.
Our specialty is delivering syndicated and custom market intelligence reports with in-depth analysis containing key market insights in a timely and cost-effective manner.

This release was published on openPR.